Results 181 to 190 of about 8,112 (240)

A Treat-to-Target approach in hereditary angioedema: expert consensus from a European committee. [PDF]

open access: yesFront Immunol
Cancian M   +10 more
europepmc   +1 more source

Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 Weeks.

open access: yesInt Arch Allergy Immunol
Riedl MA   +6 more
europepmc   +1 more source

Association Between the Angioedema Control Test and Attack Frequency in Hereditary Angioedema. [PDF]

open access: yesClin Transl Allergy
Yarlas A   +7 more
europepmc   +1 more source

Hereditary Angioedema

Immunology and Allergy Clinics of North America, 2022
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder that usual results from a decreased level of functional C1-INH and clinically manifests with intermittent attacks of swelling of the subcutaneous tissue or submucosal layers of the respiratory or gastrointestinal tracts.
R Gentry, Wilkerson, Joseph J, Moellman
openaire   +3 more sources

Hereditary Angioedema in Pregnancy

Obstetrical & Gynecological Survey, 2021
Importance Hereditary angioedema is a rare disease of potentially life-threatening attacks of angioedema that can affect patients of all ages, including women of childbearing age. Pregnancy can affect the course of the disease and the choice of treatment used. It is important for the care providers to recognize this disease and
Irene I, Chair   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy